首页> 美国卫生研究院文献>other >What Are the Recommended Timing and Screening Modalities in Women at Higher Risk for Developing Breast Cancer? A Clin-IQ
【2h】

What Are the Recommended Timing and Screening Modalities in Women at Higher Risk for Developing Breast Cancer? A Clin-IQ

机译:在罹患乳腺癌风险较高的女性中建议的时机和筛查方式是什么?临床智商

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Early detection of breast cancer is desirable to prevent progression to advanced disease. This subject has been one of significant study and debate for women at normal risk, and recommendations continue to evolve. However, with regard to women at high risk, the recommendations from various health care professional organizations, including the recent recommendations from the United States Preventative Services Task Force, are different and also inconsistent concerning when to begin screening and which modalities should be used. We review several randomized controlled trials and consensus opinions regarding when to begin screening for breast cancer and how to best screen women at high risk. Specifically, we address women with known personal history of breast cancer, prior mantle radiation, or specific family history (including genetic family history) of breast cancer. The purpose of this inquiry is to present current evidence and suggest a clinical pathway regarding the screening of women at high risk for breast cancer.
机译:早期发现乳腺癌对于防止进展为晚期疾病是理想的。对于处于正常风险中的女性,该主题一直是重要的研究和辩论之一,并且建议也在不断发展。但是,对于高危妇女,来自各种卫生保健专业组织的建议,包括美国预防服务工作队的最新建议,是不同的,并且在何时开始筛查以及应采用哪种方式方面也不一致。我们回顾了几项关于何时开始筛查乳腺癌以及如何最好地筛查高危女性的随机对照试验和共识性意见。具体来说,我们针对具有已知乳腺癌个人病史,先前的放射线辐射或特定的乳腺癌家族史(包括遗传家族史)的女性。这项调查的目的是提供当前证据并提出有关筛查乳腺癌高危女性的临床途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号